BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26761946)

  • 1. Homozygous Ala65Pro Mutation with V89L Polymorphism in SRD5A2 Deficiency.
    Eren E; Edgünlü T; Asut E; Karakaş Çelik S
    J Clin Res Pediatr Endocrinol; 2016 Jun; 8(2):218-23. PubMed ID: 26761946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
    Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
    J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype, genotype and gender identity in a large cohort of patients from India with 5α-reductase 2 deficiency.
    Shabir I; Khurana ML; Joseph AA; Eunice M; Mehta M; Ammini AC
    Andrology; 2015 Nov; 3(6):1132-9. PubMed ID: 26453174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency.
    Sahu R; Boddula R; Sharma P; Bhatia V; Greaves R; Rao S; Desai M; Wakhlu A; Phadke S; Shukla M; Dabadghao P; Mehrotra RN; Bhatia E
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):247-54. PubMed ID: 19492581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SRD5A2 mutation in a Taiwanese newborn with ambiguous genitalia.
    Tsai MC; Chou YY; Lin SJ; Tsai LP
    Kaohsiung J Med Sci; 2012 Apr; 28(4):231-5. PubMed ID: 22453073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.
    Hackel C; Oliveira LE; Ferraz LF; Tonini MM; Silva DN; Toralles MB; Stuchi-Perez EG; Guerra-Junior G
    J Mol Med (Berl); 2005 Jul; 83(7):569-76. PubMed ID: 15770495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.
    Skordis N; Neocleous V; Kyriakou A; Efstathiou E; Sertedaki A; Philibert P; Phylactou LA; Lumbroso S; Sultan C
    J Endocrinol Invest; 2010 Dec; 33(11):810-4. PubMed ID: 20511729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: the P212R substitution of the steroid 5alpha-reductase 2 may constitute an ancestral founder mutation in Mexican patients.
    Vilchis F; Ramos L; Méndez JP; Benavides S; Canto P; Chávez B
    J Androl; 2010; 31(4):358-64. PubMed ID: 20019388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undervirilization in XY newborns may hide a 5α-reductase deficiency: report of three new SRD5A2 gene mutations.
    Maimoun L; Philibert P; Cammas B; Audran F; Pienkowski C; Kurtz F; Heinrich C; Cartigny M; Sultan C
    Int J Androl; 2010 Dec; 33(6):841-7. PubMed ID: 20132346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect.
    Skordis N; Patsalis PC; Bacopoulou I; Sismani C; Sultan C; Lumbroso S
    J Pediatr Endocrinol Metab; 2005 Mar; 18(3):241-6. PubMed ID: 15813602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late diagnosis of 5alpha steroid-reductase deficiency due to IVS12A>G mutation of the SRD5a2 gene in an adolescent girl presented with primary amenorrhea.
    Skordis N; Shammas C; Efstathiou E; Sertedaki A; Neocleous V; Phylactou L
    Hormones (Athens); 2011; 10(3):230-5. PubMed ID: 22001134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency.
    Sasaki G; Ishii T; Hori N; Amano N; Homma K; Sato S; Hasegawa T
    Endocr J; 2019 Sep; 66(9):837-842. PubMed ID: 31178538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency.
    Vilchis F; Méndez JP; Canto P; Lieberman E; Chávez B
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):383-7. PubMed ID: 10718838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nucleotide insertions in two unrelated Indian patients with 5α reductase 2 deficiency leading to premature termination of SRD5A2 enzyme.
    Shabir I; Khurana ML; Marumudi E; Khadgawat R; Ammini AC
    Steroids; 2013 Dec; 78(12-13):1159-63. PubMed ID: 24012728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency.
    Ko JM; Cheon CK; Kim GH; Kim SH; Kim KS; Yoo HW
    Horm Res Paediatr; 2010; 73(1):41-8. PubMed ID: 20190539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.
    Can S; Zhu YS; Cai LQ; Ling Q; Katz MD; Akgun S; Shackleton CH; Imperato-McGinley J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):560-9. PubMed ID: 9467575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
    Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
    Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation.
    Fernández-Cancio M; Audí L; Andaluz P; Torán N; Piró C; Albisu M; Gussinyé M; Yeste D; Clemente M; Martínez-Mora J; Blanco A; Granada ML; Marco M; Ferragut J; López-Siguero JP; Beneyto M; Carles C; Carrascosa A
    Int J Androl; 2011 Dec; 34(6 Pt 2):e526-35. PubMed ID: 21631525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey.
    Abacı A; Çatlı G; Kırbıyık Ö; Şahin NM; Abalı ZY; Ünal E; Şıklar Z; Mengen E; Özen S; Güran T; Kara C; Yıldız M; Eren E; Nalbantoğlu Ö; Güven A; Çayır A; Akbaş ED; Kor Y; Çürek Y; Aycan Z; Baş F; Darcan Ş; Berberoğlu M
    J Endocrinol Invest; 2019 Apr; 42(4):453-470. PubMed ID: 30132287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and molecular characteristics in eleven Chinese patients with 5α-reductase Type 2 deficiency.
    Zhu H; Liu W; Han B; Fan M; Zhao S; Wang H; Lu Y; Pan C; Chen F; Chen M; Song H; Cheng K; Qiao J
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):711-20. PubMed ID: 24665940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.